Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
SKB-571 in Pancreatic Cancer: NCT07814066 Clinical Landscape Report 2026
9 min read
SKB-571 in Pancreatic Cancer: NCT07814066 Clinical Landscape Report 2026
11 September 2026
NCT07814066 clinical landscape for Pancreatic Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
JANX-007 in Metastatic castration-resistant prostate cancer: NCT07813637 Clinical Landscape Report 2026
9 min read
JANX-007 in Metastatic castration-resistant prostate cancer: NCT07813637 Clinical Landscape Report 2026
11 September 2026
NCT07813637 clinical landscape for Metastatic castration-resistant prostate cancer: endpoints, sponsor, phase, geography, readouts, asset context and develop…
Read →
HRS-1597 in Obesity: NCT07808918 Clinical Landscape Report 2026
9 min read
HRS-1597 in Obesity: NCT07808918 Clinical Landscape Report 2026
11 September 2026
NCT07808918 clinical landscape for Obesity: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Bevacizumab biosimilar (Bio-Thera Solutions) in Platinum-Resistant Primary Peritoneal Carcinoma: NCT07811271 Clinical Landscape Report 2026
9 min read
Bevacizumab biosimilar (Bio-Thera Solutions) in Platinum-Resistant Primary Peritoneal Carcinoma: NCT07811271 Clinical Landscape Report 2026
11 September 2026
NCT07811271 clinical landscape for Platinum-Resistant Primary Peritoneal Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and develop…
Read →
Pembrolizumab in metastatic non-small cell lung cancer: NCT07809256 Clinical Landscape Report 2026
9 min read
Pembrolizumab in metastatic non-small cell lung cancer: NCT07809256 Clinical Landscape Report 2026
11 September 2026
NCT07809256 clinical landscape for metastatic non-small cell lung cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white…
Read →
Universal STAR-T Cell(BriSTAR Immunotech) in Myasthenia Gravis: NCT07714798 Clinical Landscape Report 2026
9 min read
Universal STAR-T Cell(BriSTAR Immunotech) in Myasthenia Gravis: NCT07714798 Clinical Landscape Report 2026
11 September 2026
NCT07714798 clinical landscape for Myasthenia Gravis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Dexamethasone Sodium Phosphate in Relapse multiple myeloma: NCT07811986 Clinical Landscape Report 2026
9 min read
Dexamethasone Sodium Phosphate in Relapse multiple myeloma: NCT07811986 Clinical Landscape Report 2026
11 September 2026
NCT07811986 clinical landscape for Relapse multiple myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Zugocaptagene Geleucel in Neuromyelitis Optica: NCT07804004 Clinical Landscape Report 2026
9 min read
Zugocaptagene Geleucel in Neuromyelitis Optica: NCT07804004 Clinical Landscape Report 2026
11 September 2026
NCT07804004 clinical landscape for Neuromyelitis Optica: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Polyethylene glycol 4000 in Inflammatory Bowel Diseases: NCT07786363 Clinical Landscape Report 2026
9 min read
Polyethylene glycol 4000 in Inflammatory Bowel Diseases: NCT07786363 Clinical Landscape Report 2026
11 September 2026
NCT07786363 clinical landscape for Inflammatory Bowel Diseases: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Temozolomide in Melanoma, Cutaneous Malignant: NCT07807878 Clinical Landscape Report 2026
9 min read
Temozolomide in Melanoma, Cutaneous Malignant: NCT07807878 Clinical Landscape Report 2026
11 September 2026
NCT07807878 clinical landscape for Melanoma, Cutaneous Malignant: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Mazdutide in Metabolic Dysfunction Associated Steatohepatitis: NCT07718126 Clinical Landscape Report 2026
9 min read
Mazdutide in Metabolic Dysfunction Associated Steatohepatitis: NCT07718126 Clinical Landscape Report 2026
11 September 2026
NCT07718126 clinical landscape for Metabolic Dysfunction Associated Steatohepatitis: endpoints, sponsor, phase, geography, readouts, asset context and develo…
Read →
[18F]FAPI-74 in Fibrosis, Liver: NCT07705074 Clinical Landscape Report 2026
9 min read
[18F]FAPI-74 in Fibrosis, Liver: NCT07705074 Clinical Landscape Report 2026
11 September 2026
NCT07705074 clinical landscape for Fibrosis, Liver: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →